{"id":"https://openalex.org/W4239106264","doi":"https://doi.org/10.1093/ibd/izaa347.141","title":"SPOSAB ABP 501 - A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501","display_name":"SPOSAB ABP 501 - A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W4239106264","doi":"https://doi.org/10.1093/ibd/izaa347.141"},"language":"en","primary_location":{"id":"doi:10.1093/ibd/izaa347.141","doi":"https://doi.org/10.1093/ibd/izaa347.141","is_oa":false,"landing_page_url":"https://doi.org/10.1093/ibd/izaa347.141","pdf_url":null,"source":{"id":"https://openalex.org/S45123234","display_name":"Inflammatory Bowel Diseases","issn_l":"1078-0998","issn":["1078-0998","1536-4844"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Inflammatory Bowel Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066459416","display_name":"Fabio Salvatore Macaluso","orcid":"https://orcid.org/0000-0001-5128-3846","observed_orcids":["https://orcid.org/0000-0001-5128-3846"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fabio Salvatore Macaluso","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108724894","display_name":"Maria Cappello","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Cappello","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040727807","display_name":"Anita Busacca","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anita Busacca","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010932748","display_name":"Walter Fries","orcid":"https://orcid.org/0000-0001-6159-7478","observed_orcids":["https://orcid.org/0000-0001-6159-7478"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Walter Fries","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102749080","display_name":"Anna Viola","orcid":"https://orcid.org/0000-0002-1733-6489","observed_orcids":["https://orcid.org/0000-0002-1733-6489"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Viola","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052702662","display_name":"Giuseppe Costantino","orcid":"https://orcid.org/0000-0003-4369-4252","observed_orcids":["https://orcid.org/0000-0003-4369-4252"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giuseppe Costantino","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067231655","display_name":"Antonio Magnano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonio Magnano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002268513","display_name":"Elisa Vinci","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elisa Vinci","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075167160","display_name":"Concetta Ferracane","orcid":"https://orcid.org/0009-0002-2686-191X","observed_orcids":["https://orcid.org/0009-0002-2686-191X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Concetta Ferracane","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102776826","display_name":"Antonino Carlo Privitera","orcid":"https://orcid.org/0000-0002-8978-1661","observed_orcids":["https://orcid.org/0000-0002-8978-1661"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonino Carlo Privitera","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076099732","display_name":"Giovita A. Piccillo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giovita Piccillo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064008147","display_name":"Nunzio Belluardo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nunzio Belluardo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081757491","display_name":"Emiliano Giangreco","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emiliano Giangreco","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018231363","display_name":"Claudio Romano","orcid":"https://orcid.org/0000-0001-8827-2091","observed_orcids":["https://orcid.org/0000-0001-8827-2091"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claudio Romano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070847739","display_name":"Michele Citrano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michele Citrano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018141422","display_name":"Francesco Graziano","orcid":"https://orcid.org/0000-0002-4896-1842","observed_orcids":["https://orcid.org/0000-0002-4896-1842","https://orcid.org/0009-0003-5750-0559"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesco Graziano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052840053","display_name":"Serena Garufi","orcid":"https://orcid.org/0000-0001-5904-1374","observed_orcids":["https://orcid.org/0000-0001-5904-1374"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Serena Garufi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029574178","display_name":"Carmelo Bertolami","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carmelo Bertolami","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003162215","display_name":"Marco Ventimiglia","orcid":"https://orcid.org/0000-0002-3469-4720","observed_orcids":["https://orcid.org/0000-0002-3469-4720"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marco Ventimiglia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044608835","display_name":"Barbara Scrivo","orcid":"https://orcid.org/0000-0002-0329-9488","observed_orcids":["https://orcid.org/0000-0002-0329-9488"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barbara Scrivo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016678827","display_name":"Sara Renna","orcid":"https://orcid.org/0000-0001-8270-2978","observed_orcids":["https://orcid.org/0000-0001-8270-2978"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sara Renna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081551616","display_name":"Giulia Rizzuto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rizzuto Giulia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090729567","display_name":"Angelo Cas\u00e0","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angelo Cas\u00e0","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5008838958","display_name":"Ambrogio Orlando","orcid":"https://orcid.org/0000-0002-5298-2638","observed_orcids":["https://orcid.org/0000-0002-5298-2638"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ambrogio Orlando","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3317,"currency":"USD","value_usd":3317},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"Supplement_1","first_page":"S59","last_page":"S59"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.850600004196167,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.850600004196167,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.14720000326633453,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adalimumab-biosimilar","display_name":"adalimumab biosimilar","score":0.8989999890327454}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8988086581230164},{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.7885544300079346},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7525753974914551},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6113678812980652},{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.608852744102478},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5721455216407776},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.5618403553962708},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5236663222312927},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.47304171323776245},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4357777237892151},{"id":"https://openalex.org/C2777785397","wikidata":"https://www.wikidata.org/wiki/Q492194","display_name":"Group B","level":2,"score":0.4234158992767334},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3343973159790039},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.23130446672439575},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/ibd/izaa347.141","doi":"https://doi.org/10.1093/ibd/izaa347.141","is_oa":false,"landing_page_url":"https://doi.org/10.1093/ibd/izaa347.141","pdf_url":null,"source":{"id":"https://openalex.org/S45123234","display_name":"Inflammatory Bowel Diseases","issn_l":"1078-0998","issn":["1078-0998","1536-4844"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Inflammatory Bowel Diseases","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3171746692","https://openalex.org/W4206972220","https://openalex.org/W4387869075","https://openalex.org/W3160525426","https://openalex.org/W3167168161","https://openalex.org/W2999134967","https://openalex.org/W4386842242","https://openalex.org/W7128970101","https://openalex.org/W3000504821","https://openalex.org/W4280638666"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"and":[2,69,82,164,219,225,249],"Aims":[3],"There":[4],"are":[5],"few":[6],"clinical":[7,192],"data":[8],"on":[9],"Adalimumab":[10],"(ADA)":[11],"biosimilars":[12],"in":[13,54,127,148,167,212],"inflammatory":[14],"bowel":[15],"disease.":[16],"Methods":[17],"SPOSAB":[18],"ABP":[19,46,102,228,245],"501":[20,47,229,246],"is":[21],"a":[22,118,191],"multicenter,":[23],"observational,":[24],"prospective":[25],"study":[26],"performed":[27],"among":[28,146,165],"the":[29,32,49,52],"cohort":[30],"of":[31,51,121,142,227],"Sicilian":[33],"Network":[34],"for":[35,210,238],"Inflammatory":[36],"Bowel":[37],"Disease.":[38],"All":[39],"consecutive":[40],"patients":[41,106,129,147,166,185,211],"treated":[42],"with":[43,117,152,171,216],"ADA":[44,81,99,239],"biosimilar":[45],"from":[48,98,242],"introduction":[50],"drug":[53],"Sicily":[55],"(February":[56],"2019)":[57],"to":[58,65,80,84,89,93,101,231,235,244],"February":[59],"2020":[60],"(12":[61],"months)":[62],"were":[63,72,115,208],"enrolled":[64],"assess":[66],"its":[67],"safety":[68],"effectiveness.":[70],"Patients":[71],"divided":[73],"into":[74],"3":[75],"groups:":[76],"group":[77,86,95,149,153,168,172,213,217],"A,":[78],"na\u00efve":[79,83,88],"anti-TNFs;":[85,94],"B,":[87],"ADA,":[90],"previously":[91],"exposed":[92],"C:":[96],"switched":[97],"originator":[100,243],"501.":[103],"Results":[104],"559":[105],"(median":[107],"age":[108],"39":[109],"years;":[110],"CD":[111],"88.0%,":[112],"UC":[113],"12.0%)":[114],"included,":[116],"follow-up":[119],"time":[120],"403.4":[122],"patient-years.":[123],"Thirty-six":[124],"SAEs":[125,143],"occurred":[126],"36":[128],"[(6.4%":[130],"-":[131],"incidence":[132],"rate":[133],"(IR):":[134],"8.9":[135],"per":[136,158,177],"100":[137,159,178],"person-years":[138],"(PY)].":[139],"The":[140],"IR":[141,161,180],"was":[144,247],"higher":[145],"A":[150,218],"compared":[151,170,215],"C":[154,173,214],"(17.4":[155],"vs.":[156,175],"4.8":[157,176],"PY;":[160,179],"ratio=3.61;":[162],"p<0.001)":[163],"B":[169,220],"(16.4":[174],"ratio=3.42;":[181],"p=0.041).":[182],"Among":[183],"ADA-na\u00efve":[184],"(group":[186],"A+B),":[187],"188":[188],"(85.8%)":[189],"had":[190],"response":[193],"after":[194],"12":[195],"weeks,":[196],"including":[197],"165":[198],"(75.3%)":[199],"who":[200],"achieved":[201],"steroid-free":[202],"remission.":[203],"Higher":[204],"treatment":[205],"persistence":[206],"estimates":[207],"reported":[209,237],"(log-rank":[221],"p<0.001).":[222],"Conclusions":[223],"Safety":[224],"effectiveness":[226],"seem":[230],"be":[232],"overall":[233],"similar":[234],"those":[236],"originator.":[240],"Switching":[241],"safe":[248],"effective.":[250]},"counts_by_year":[],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2022-05-12T00:00:00"}